Opioid Use Disorder: A Qualitative Exploratory Analysis of Potential Misunderstandings in Patients with Chronic Non-Cancer Pain
Neele Kufeld,Klaus Weckbecker,Johannes Michalak,Winfried Häuser,Frank Petzke,Norbert Scherbaum,Michael Specka,Alexandra Schmidt,Alexandra Piotrowski,Christine Kersting,Johannes Just
DOI: https://doi.org/10.2147/jpr.s445153
IF: 2.8319
2024-03-05
Journal of Pain Research
Abstract:Neele Kufeld, 1 Klaus Weckbecker, 1 Johannes Michalak, 2 Winfried Häuser, 3 Frank Petzke, 4 Norbert Scherbaum, 5 Michael Specka, 5 Alexandra Schmidt, 6 Alexandra Piotrowski, 6 Christine Kersting, 6 Johannes Maximilian Just 1 1 Chair of General Practice I and Interprofessional Care, Institute of General Practice and Primary Care, Faculty of Health, Witten/Herdecke University, Witten, Germany; 2 Department of Psychology and Psychotherapy, Witten/Herdecke University, Witten, Germany; 3 Department Psychosomatic Medicine and Psychotherapy, Technical University Munich, Munich, Germany; 4 Department of Anesthesiology, Pain Medicine, University Medical Center Göttingen, Göttingen, Germany; 5 Department of Psychiatry and Psychotherapy, LVR University Hospital Essen, University of Duisburg-Essen, Essen, Germany; 6 Chair of General Practice II and Patient-Centredness in Primary Care, Institute of General Practice and Primary Care, Faculty of Health, Witten/Herdecke University, Witten, Germany Correspondence: Neele Kufeld, General Practice I and Interprofessional Care, Institute of General Practice and Primary Care, Witten/Herdecke University, Alfred-Herrhausen-Straße 50, Witten, 58455, Germany, Tel +49 15120923736, Fax +49 2303 926-745, Email Purpose: Substance use disorders (SUD) are a challenging comorbidity in patients with chronic non-cancer pain (CNCP) as they complicate diagnosis and therapy, especially when opioids are part of the therapeutic regimen. A definite diagnosis of opioid use disorder (OUD) in patients with CNCP on long-term opioid therapy (LTOT) is a prerequisite for effective and targeted therapy but may be complicated as some criteria of OUD might be attributed to the desire of the patient to relieve the pain. For instance, the desire to increase the dose can be based on both a SUD as well as inadequate pain therapy. Many scientific studies use standardized questions. Therefore, potential misunderstandings due to possible diagnostic overlaps often cannot be clarified. Methods: 14 qualitative guided interviews were conducted and analyzed (Kuckartz content analysis), with the intention to verify if patient's initial response to simple questions based on the wording of the DSM-5, as commonly used in research and practice, were consistent with the results of a more in-depth inquiry. Results: The results suggest that without in-depth investigation, there is a particular risk of false-positive assessment of the DSM-5 criteria for OUD when opioids are prescribed, especially when the questions are considered independently of chronic pain. The risk of a false-negative assessment has also been shown in isolated cases. Conclusion: Only after asking for and describing specific situations it was possible to determine whether the patient's positive or negative answers were based on a misunderstanding of the question. To avoid misdiagnosis, staff conducting DSM-5 interviews should be trained in pain-specific follow-up questions that may help to uncover diagnostic confounding. Keywords: chronic pain, substance use disorder, diagnoses, DSM 5 Substance use disorders are a common comorbidity in patients with chronic pain, which presents a challenge in diagnostics and therapy. 1 Opioids are particularly important in pharmacological management, but they are also highly addictive substances. The use of questions based on the DSM-5 criteria to diagnose opioid use disorder (OUD) is widespread. 2 There are eleven diagnostic criteria for the diagnosis of OUD in the DSM-5. Accounting for the special situation of patients who receive opioids solely under appropriate medical supervision, two of these criteria (development of tolerance and withdrawal symptoms) are omitted if opioids are prescribed for pain therapy seeking to improve diagnostic accuracy and avoid overdiagnosis. Opioid use is considered problematic if at least two criteria are met. It is divided into mild (2–3 symptoms), moderate (4–5 symptoms) and severe (6 or more symptoms) prescription OUD. 2 High inconsistency has been found in the diagnosis of opioid use disorder among patients with CNCP who are receiving LTOT. Challenges emerge when diagnosing opioid use disorder using questions based on the DSM-5, due to the different understandings of the clinical picture among experts and the use and definition of terms. 3–5 Boscarino et al argue that a patient's understanding of the question they receive and their motivation behind their answer may also be crucial in making a diagnosis. 6 Some DSM-5 criteria might not only represent use disorder and may be confounded -Abstract Truncated-
clinical neurology